Tumour histology and primary site but not MDM2 amplification levels are prognostic for clinical outcomes in well differentiated and dedifferentiated liposarcoma

被引：0
|
作者：
Chew, W. H. W. [1 ]
Chan, J. Y. [1 ]
Goh, W. L. [1 ]
Lim, J. H. C. [2 ]
Tan, S. H. [2 ]
Somasundaram, N. [1 ]
Poon, E. Y. L. [1 ]
Lim, A. S. T. [3 ]
Tan, M. H. [4 ]
Soo, K. C. [5 ]
Teo, M. [5 ]
Tay, T. K. Y. [6 ]
Selvarajan, S. [6 ]
Sittampalam, K. [6 ]
Quek, R. [1 ]
机构：
[1] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore
[2] Natl Canc Ctr Singapore, Div Clin Trials & Epidemiol Sci, Singapore, Singapore
[3] Singapore Gen Hosp, Dept Mol Pathol, Singapore, Singapore
[4] Singapore Gen Hosp, Dept Orthopaed Surg, Singapore, Singapore
[5] Natl Canc Ctr Singapore, Div Surg Oncol, Singapore, Singapore
[6] Singapore Gen Hosp, Dept Anat Pathol, Singapore, Singapore
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
487O
引用
收藏
页码：150 / 150
页数：1
相关论文
共 50 条
  • [21] Prognostic factors and expression of MDM2 in patients with primary extremity liposarcoma
    Bispo, Rosalvo Zosimo, Jr.
    de Camargo, Olavo Pires
    de Oliveira, Claudia Regina G. C. M.
    Filippi, Renee Zon
    Baptista, Andre Mathias
    Caiero, Marcelo Tadeu
    CLINICS, 2008, 63 (02) : 157 - 164
  • [22] Prognostic significance of the MDM2/HMGA2 ratio and histological tumor grade in dedifferentiated liposarcoma
    Yamashita, Kyoko
    Kohashi, Kenichi
    Yamada, Yuichi
    Akatsuka, Shinya
    Ikuta, Kunihiro
    Nishida, Yoshihiro
    Toyokuni, Shinya
    Oda, Yoshinao
    GENES CHROMOSOMES & CANCER, 2021, 60 (01): : 26 - 37
  • [23] A novel HMGA2::KITLG fusion in a dedifferentiated liposarcoma with amplification of MDM2 and HMGA2
    Zhou, Shishan
    Zhang, Changliang
    Zhang, Zhipeng
    Hu, Yongbin
    Zhao, Lina
    Hu, Wentao
    Chen, Si
    Li, Bin
    Xiao, Sheng
    GENES CHROMOSOMES & CANCER, 2024, 63 (01):
  • [24] MDM2-p53 Pathway Status in Clinical Samples of Well-Differentiated and Dedifferentiated Liposarcoma.
    Kumagai, A.
    Motoi, T.
    Yoshida, A.
    Imamura, T.
    Fukusato, T.
    MODERN PATHOLOGY, 2011, 24 : 17A - 17A
  • [25] Retroperitoneal dedifferentiated liposarcoma lacking MDM2 amplification in a patient with a germ line CHEK2 mutation
    Navid Sadri
    Lea F. Surrey
    Douglas L. Fraker
    Paul J. Zhang
    Virchows Archiv, 2014, 464 : 505 - 509
  • [26] Retroperitoneal dedifferentiated liposarcoma lacking MDM2 amplification in a patient with a germ line CHEK2 mutation
    Sadri, Navid
    Surrey, Lea F.
    Fraker, Douglas L.
    Zhang, Paul J.
    VIRCHOWS ARCHIV, 2014, 464 (04) : 505 - 509
  • [27] MRI characteristics of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma: retrospective comparison with histology and MDM2 geneamplification
    Mélanie Brisson
    Takeshi Kashima
    David Delaney
    Roberto Tirabosco
    Andrew Clarke
    Suzie Cro
    Adrienne M. Flanagan
    Paul O’Donnell
    Skeletal Radiology, 2013, 42 : 635 - 647
  • [28] A case of dedifferentiated liposarcoma with well-differentiated liposarcomatous, inflammatory myofibroblastic tumor-like, and low- and high-grade osteosarcomatous components: common MDM2 amplification supporting divergent morphological change of well-differentiated liposarcoma
    Tajima, Shogo
    Koda, Kenji
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 2382 - 2388
  • [29] Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours
    Aleixo, P. B.
    Hartmann, A. A.
    Menezes, I. C.
    Meurer, R. T.
    Oliveira, A. M.
    JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (12) : 1127 - 1135
  • [30] Well-Differentiated Liposarcoma of the Hypopharynx Exhibiting Myxoid Liposarcoma-like Morphology with MDM2 and DDIT3 Co-Amplification
    Khaled A. Murshed
    Hayan Abo Samra
    Adham Ammar
    Head and Neck Pathology, 2022, 16 : 288 - 293
12345